Pattern and progression of cognitive decline in Alzheimer's disease: Role of premorbid intelligence and ApoE genotype

Dementia and Geriatric Cognitive Disorders

Volumn 24, Issue 6, 2007, Pages 483-491

  Bracco, Laura ^a,b   Piccini, Carolina ^a   Baccini, Michela ^a   Bessi, Valentina ^a   Biancucci, Federica ^a   Nacmias, Benedetta ^a   Bagnoli, Silvia ^a   Sorbi, Sandro ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Department of Neurological and Psychiatric Sciences ^*  (Italy)

Author keywords

Alzheimer's disease; Apolipoprotein E; Cognitive decline; Cognitive performance; Education; Premorbid intelligence

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; BRAIN FUNCTION; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; INTELLIGENCE; INTELLIGENCE TEST; MAJOR CLINICAL STUDY; MALE; MEMORY; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL;

AGED; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; COGNITION DISORDERS; DISEASE PROGRESSION; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INTELLIGENCE; MALE; NEUROPSYCHOLOGICAL TESTS; SEVERITY OF ILLNESS INDEX;

EID: 36448993703     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000111081     Document Type: Article

References (80)

1. Zhang MY, Katzman R, Salmon D, Jin H, Cai GJ, Wang ZY, Qu GY, Grant I, Yu E, Levy P, et al: The prevalence of dementia and Alzheimer's disease in Shanghai, China: impact of age, gender, and education. Ann Neurol 1990;27:428-437.
2. Stern Y, Gurland B, Tatemichi TK, Tang MX, Wilder D, Mayeux R. Influence of education and occupation on the incidence of Alzheimer's disease. JAMA 1994;271:1004-1010.
3. Letenneur L, Gilleron V, Commenges D, Helmer C, Orgogozo JM, Dartigues JF: Are sex and educational level independent predictors of dementia and Alzheimer's disease? Incidence data from the PAQUID project. J Neurol Neurosurg Psychiatry 1999;66:177-183.
4. Ravaglia G, Forti P, Maioli F, Martelli M, Servadei L, Brunetti N, Dal Monte E, Bianchin M, Mariani E: Incidence and etiology of dementia in a large elderly Italian population. Neurology 2005;64:1525-1530.
5. Caamano-Isorna F, Corral M, Montes-Martinez A, Takkouche B: Education and dementia: a meta-analytic study. Neuroepidemiology 2006;26:226-232.
6. Chandra V, Pandav R, Dodge HH, Johnston JM, Belle SH, DeKosky ST, Ganguli M: Incidence of Alzheimer's disease in a rural community in India: the Indo-US study. Neurology 2001;57:985-989.
7. Cobb JL, Wolf PA, Au R, White R, D'Agostino RB: The effect of education on the incidence of dementia and Alzheimer's disease in the Framingham Study. Neurology 1995;45:1707-1712.
8. Paykel ES, Brayne C, Huppert FA, Gill C, Barkley C, Gehlhaar E, Beardsall L, Girling DM, Pollitt P, O'Connor D: Incidence of dementia in a population older than 75 years in the United Kingdom. Arch Gen Psychiatry 1994;51:325-332.
9. Whalley LJ, Starr JM, Athawes R, Hunter D, Pattie A, Deary IJ: Childhood mental ability and dementia. Neurology 2000;55:1455-1459.
10. Bennett DA, Wilson RS, Schneider JA, Evans DA, Mendes de Leon CF, Arnold SE, Barnes LL, Bienias JL: Education modifies the relation of AD pathology to level of cognitive function in older persons. Neurology 2003;60:1909-1915.
11. Baxter LC, Caselli RJ, Johnson SC, Reiman E, Osborne D: Apolipoprotein E epsilon 4 affects new learning in cognitively normal individuals at risk for Alzheimer's disease. Neurobiol Aging 2003;24:947-952.
12. Stern Y: What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc 2002;8:448-460.
13. Tuokko H, Garrett DD, McDowell I, Silverberg N, Kristjansson B: Cognitive decline in high-functioning older adults: reserve or ascertainment bias? Aging Ment Health 2003;7:259-270.
14. Stern Y, Alexander GE, Prohovnik I, May - eux R: Inverse relationship between education and parietotemporal perfusion deficit in Alzheimer's disease. Ann Neurol 1992;32:371-375.
15. Satz P: Brain reserve capacity on symptom onset after brain injury: a formulation and review of evidence for the threshold theory. Neuropsychology 1993;7:237-295.
16. Katzman R: Education and the prevalence of dementia and Alzheimer's disease. Neurology 1993;43:13-20.
17. Scarmeas N, Albert SM, Manly JJ, Stern Y: Education and rates of cognitive decline in incident Alzheimer's disease. J Neurol Neurosurg Psychiatry 2006;77:308-316.
18. Stern Y: Cognitive reserve and Alzheimer disease. Alzheimer Dis Assoc Disord 2006;20(suppl 2):S69-S74.
19. Rasmusson DX, Carson KA, Brookmeyer R, Kawas C, Brandt J: Predicting rate of cognitive decline in probable Alzheimer's disease. Brain Cogn 1996;31:133-147.
20. Stern Y, Albert S, Tang MX, Tsai WY: Rate of memory decline in AD is related to education and occupation: cognitive reserve? Neurology 1999;53:1942-1947.
21. Teri L, McCurry SM, Edland SD, Kukull WA, Larson EB: Cognitive decline in Alzheimer's disease: a longitudinal investigation of risk factors for accelerated decline. J Gerontol A Biol Sci Med Sci 1995;50A:M49-M55.
22. Unverzagt FW, Hui SL, Farlow MR, Hall KS, Hendrie HC: Cognitive decline and education in mild dementia. Neurology 1998;50:181-185.
23. Fritsch T, McClendon MJ, Smyth KA, Ogrocki PK: Effects of educational attainment and occupational status on cognitive and functional decline in persons with Alz heimer-type dementia. Int Psychogeriatr 2002;14:347-363.
24. Filley CM, Brownell HH, Albert ML: Education provides no protection against Alzheimer's disease. Neurology 1985;35:1781-1784.
25. Haxby JV, Raffaele K, Gillette J, Schapiro MB, Rapoport SI: Individual trajectories of cognitive decline in patients with dementia of the Alzheimer type. J Clin Exp Neuropsychol 1992;14:575-592.
26. Amieva H, Jacqmin-Gadda H, Orgogozo JM, Le Carret N, Helmer C, Letenneur L, Barberger-Gateau P, Fabrigoule C, Dartigues JF: The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study. Brain 2005;128:1093-1101.
27. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-923.
28. Farrer LA, Cupples LA, Haines JL, et al: Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer's disease: a meta-analysis. APOE and Alzheimer's Disease Meta Analysis Consortium. JAMA 1997;278:1349-1356.
29. Arendt T: Synaptic plasticity and cell cycle activation in neurons are alternative effector pathways: the 'Dr. Jekyll and Mr. Hyde concept' of Alzheimer's disease or the yin and yang of neuroplasticity. Prog Neurobiol 2003;71:83-248.
30. Mesulam MM: Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles. Neuron 1999;24:521-529.
31. Arendt T, Schindler C, Bruckner MK, Eschrich K, Bigl V, Zedlick D, Marcova L: Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele. J Neurosci 1997;17:516-529.
32. Small BJ, Rosnick CB, Fratiglioni L, Backman L: Apolipoprotein E and cognitive performance: a meta-analysis. Psychol Aging 2004;19:592-600.
33. Lehtovirta M, Soininen H, Helisalmi S, Mannermaa A, Helkala EL, Hartikainen P, Hanninen T, Ryynanen M, Riekkinen PJ: Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism. Neurology 1996;46:413-419.
34. Smith GE, Bohac DL, Waring SC, Kokmen E, Tangalos EG, Ivnik RJ, Petersen RC: Apolipoprotein E genotype influences cognitive 'phenotype' in patients with Alzheimer's disease but not in healthy control subjects. Neurology 1998;50:355-362.
35. Wilson RS, Schneider JA, Barnes LL, Beckett LA, Aggarwal NT, Cochran EJ, Berry-Kravis E, Bach J, Fox JH, Evans DA, Bennett DA: The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year period. Arch Neurol 2002;59:1154-1160.
36. Greenwood PM, Sunderland T, Friz JL, Parasuraman R: Genetics and visual attention: selective deficits in healthy adult carriers of the epsilon 4 allele of the apolipoprotein E gene. Proc Natl Acad Sci USA 2000;97:11661-11666.
37. Parasuraman R, Greenwood PM, Sunderland T: The apolipoprotein E gene, attention and brain function. Neuropsychology 2002;16:254-274.
38. Rosen VM, Bergeson JL, Putnam K, Harwell A, Sunderland T: Working memory and apolipoprotein E: what's the connection? Neuropsychologia 2002;40:2226-2233.
39. Basso M, Gelernter J, Yang J, MacAvoy MG, Varma P, Bronen RA, van Dyck CH: Apolipoprotein E epsilon 4 is associated with atrophy of the amygdala in Alzheimer's disease. Neurobiol Aging 2006;27:1416-1424.
40. Geroldi C, Laakso MP, DeCarli C, Beltramello A, Bianchetti A, Soininen H, Trabucchi M, Frisoni GB: Apolipoprotein E genotype and hippocampal asymmetry in Alzheimer's disease: a volumetric MRI study. J Neurol Neurosurg Psychiatry 2000;68:93-96.
41. Hashimoto M, Yasuda M, Tanimukai S, Matsui M, Hirono N, Kazui H, Mori E: Apolipoprotein E epsilon 4 and the pattern of regional brain atrophy in Alzheimer's disease. Neurology 2001;57:1461-1466.
42. Soininen H, Partanen K, Pitkanen A, Hallikainen M, Hanninen T, Helisalmi S, Mannermaa A, Ryynanen M, Koivisto K, Riekkinen P Sr: Decreased hippocampal volume asymmetry on MRIs in nondemented elderly subjects carrying the apolipoprotein E epsilon 4 allele. Neurology 1995;45:391-392.
43. Tohgi H, Takahashi S, Kato E, Homma A, Niina R, Sasaki K, Yonezawa H, Sasaki M: Reduced size of right hippocampus in 39- to 80-year-old normal subjects carrying the apolipoprotein E epsilon 4 allele. Neurosci Lett 1997;236:21-24.
44. Craft S, Teri L, Edland SD, Kukull WA, Schellenberg G, McCormick WC, Bowen JD, Larson EB: Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease. Neurology 1998;51:149-153.
45. Dal Forno G, Rasmusson DX, Brandt J, Carson KA, Brookmeyer R, Troncoso J, Kawas CH: Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease. Arch Neurol 1996;53:345-350.
46. Frisoni GB, Govoni S, Geroldi C, Bianchetti A, Calabresi L, Franceschini G, Trabucchi M: Gene dose of the epsilon 4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease. Ann Neurol 1995;37:596-604.
47. Hoyt BD, Massman PJ, Schatschneider C, Cooke N, Doody RS: Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease. Arch Neurol 2005;62:454-459.
48. Stern Y, Brandt J, Albert M, Jacobs DM, Liu X, Bell K, Marder K, Sano M, Albert S, Del-Castillo Castenada C, Bylsma F, Tycko B, Mayeux R: The absence of an apolipoprotein epsilon 4 allele is associated with a more aggressive form of Alzheimer's disease. Ann Neurol 1997;41:615-620.
49. Bunce D, Fratiglioni L, Small BJ, Winblad B, Backman L: APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging. Neurology 2004;63:816-821.
50. Growdon JH, Locascio JJ, Corkin S, Gomez-Isla T, Hyman BT: Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease. Neurology 1996;47:444-448.
51. Kleiman T, Zdanys K, Black B, Rightmer T, Grey M, Garman K, Macavoy M, Gelernter J, van Dyck C: Apolipoprotein E epsilon 4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis. Dement Geriatr Cogn Disord 2006;22:73-82.
52. Murphy GM Jr, Taylor J, Kraemer HC, Yesavage J, Tinklenberg JR: No association between apolipoprotein E epsilon 4 allele and rate of decline in Alzheimer's disease. Am J Psychiatry 1997;154:603-608.
53. Bracco L, Amaducci L, and SMID Group Italian Multicentric Study on Dementia: a protocol for data collection and clinical diagnosis of Alzheimer's disease. Neuroepidemiology 1992;11:39-45.
54. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
55. Bracco L, Amaducci L, Pedone D, et al: Italian Multicentre Study on Dementia (SMID): a neuropsychological test battery for assessing Alzheimer's disease. J Psychiatr Res 1990;24:213-226.
56. Folstein MF, Folstein SE, McHugh PR: 'Minimental state': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
57. Babcock H, Levy L: An experiment in the measurement of mental deterioration. Arch Psychol 1930;117:105-107.
58. Isaacs B, Kennie AT: The set test as an aid to the detection of dementia in old people. Br J Psychiatry 1973;123:467-470.
59. Novelli G, Papagno C, Capitani E, Laiacona M, Vallar G, Cappa SF: Tre test clinici di ricerca e produzione lessicale: taratura su soggetti normali. Arch Psychol 1986;47:477-506.
60. De Renzi E, Faglioni P: Normative data and screening power of a shortened version of the Token Test. Cortex 1978;14:41-49.
61. Arrigoni G, De Renzi E: Constructional apraxia and hemispheric locus of lesions. Cortex 1964;1:170-178.
62. Giovagnoli AR, Del Pesce M, Mascheroni S, Simoncelli M, Laiacona M, Capitani E: Trail Making Test: normative values from 287 normal adult controls. Ital J Neurol Sci 1996;17:305-309.
63. Colombo L, Sartori G, Brivio C: Stima del quoziente intellettivo tramite l'applicazione del TIB (Test di Intelligenza Breve). G Ital Psicol 2002;3:613-637.
64. Sartori G, Colombo L, Vallar G, Rusconi ML, Pinarello A: TIB: test di intelligenza breve per la valutazione del quoziente intellettivo attuale e premorboso. Professione di psicologo. G Ordine Psicol 1995;4:1-24.
65. Nelson HE: The National Adult Reading Test (NART): Test Manual. Windsor, NFER Nelson, 1982.
66. Crawford JR, Deary IJ, Starr J, Whalley LJ: The NART as an index of prior intellectual functioning: a retrospective validity study covering a 66-year interval. Psychol Med 2001;31:451-458.
67. McGurn B, Starr JM, Topfer JA, Pattie A, Whiteman MC, Lemmon HA, Whalley LJ, Deary IJ: Pronunciation of irregular words is preserved in dementia, validating premorbid IQ estimation. Neurology 2004;62:1184-1186.
68. Sorbi S, Nacmias B, Forleo P, et al: ApoE allele frequencies in Italian sporadic and familial Alzheimer's disease. Neurosci Lett 1994;177:100-102.
69. McCullagh P, Nelder JA: Generalized Linear Models, ed 2. London, Chapman & Hall, 1989.
70. Laird NM, Ware JH: Random-effects models for longitudinal data. Biometrics 1982;38:963-974.
71. R Development Core Team: R - A Language and Environment for Statistical Computing. Vienna, R Foundation for Statistical Computing, 2004 (available from http://www.R-project.org).
72. Mortimer JA: Brain reserve and the clinical expression of Alzheimer's disease. Geriatrics 1997;52(suppl 2):S50-S53.
73. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR: Brain infarction and the clinical expression of Alzheimer's disease: the Nun Study. JAMA 1997;277:813-817.
74. Marra C, Bizzarro A, Daniele A, De Luca L, Ferraccioli M, Valenza A, Brahe C, Tiziano FD, Gainotti G, Masullo C: Apolipoprotein E epsilon 4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients. Dement Geriatr Cogn Disord 2004;18:125-131.
75. van der Flier WM, Schoonenboom SN, Pijnenburg YA, Fox NC, Scheltens P: The effect of APOE genotype on clinical phenotype in Alzheimer disease. Neurology 2006;67:526-527.
76. Borroni B, Perani D, Archetti S, Agosti C, Paghera B, Bellelli G, Di Luca M, Padovani A: Functional correlates of apolipoprotein E genotype in frontotemporal lobar degeneration. BMC Neurol 2006;6:31.
77. Huang Y: Apolipoprotein E and Alzheimer disease. Neurology 2006;66(suppl 1):S79-S85.
78. Shadlen MF, Larson EB, Wang L, Phelan EA, McCormick WC, Jolley L, Teri L, van Belle G: Education modifies the effect of apolipoprotein epsilon 4 on cognitive decline. Neurobiol Aging 2005;26:17-24.
79. Whalley LJ, Dick FD, McNeill G: A life-course approach to the aetiology of late-onset dementias. Lancet Neurol 2006;5:87-96.
80. Drachman DA: Aging of the brain, entropy, and Alzheimer disease. Neurology 2006;67:1340-1352.